Muscle wasting: The gut microbiota as a new therapeutic target?

被引:146
|
作者
Bindels, Laure B. [1 ]
Delzenne, Nathalie M. [1 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium
关键词
Muscle wasting; Gut microbiota; Undernutrition; Cachexia; Probiotics; Prebiotics; SKELETAL-MUSCLE; KAPPA-B; OBESITY; MODULATION; ACTIVATION; MALNUTRITION; RESISTANCE; AUTOPHAGY; PROTECTS; CACHEXIA;
D O I
10.1016/j.biocel.2013.06.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Muscle wasting is characterized by a loss of muscle mass and strength, and occurs in several pathological conditions such as cancer, chronic heart failure, chronic infection and malnutrition. Muscle wasting can be caused by inflammation and inappropriate nutritional status. Interestingly, gut microbiota has recently been proposed as an environmental factor involved, among others, in energy sparing from the diet, and in the regulation of host immunity and metabolism. This review presents evidence supporting the existence of a gut microbiota-muscle axis and discusses the potential role and therapeutic interest of gut microbiota in muscle wasting, specifically in the context of cancer and malnutrition. This review also proposes possible molecular mechanisms underlying the gut microbiota-muscle axis. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2186 / 2190
页数:5
相关论文
共 50 条
  • [1] The critical role of gut microbiota dysbiosis in skeletal muscle wasting: a systematic review
    Nikkhah, Amirabbas
    Ejtahed, Hanieh-Sadat
    Ettehad Marvasti, Fateme
    Taghavi, MinaSadat
    Pakmehr, Azin
    Hajipour, Firouzeh
    Larijani, Bagher
    JOURNAL OF APPLIED MICROBIOLOGY, 2023, 134 (01)
  • [2] Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
    Yuan, Suxin
    Cai, Zhengyao
    Luan, Xingzhao
    Wang, Haibo
    Zhong, Yi
    Deng, Li
    Feng, Jian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Gut Microbiota as a Therapeutic Target for Metabolic Disorders
    Okubo, Hirofumi
    Nakatsu, Yusuke
    Kushiyama, Akifumi
    Yamamotoya, Takeshi
    Matsunaga, Yasuka
    Inoue, Masa-ki
    Fujishiro, Midori
    Sakoda, Hideaki
    Ohno, Haruya
    Yoneda, Masayasu
    Ono, Hiraku
    Asano, Tomoichiro
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (09) : 984 - 1001
  • [4] The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats
    Chen, Haitao
    Xu, Chao
    Zhang, Fan
    Liu, Yu
    Guo, Yong
    Yao, Qinghua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1049 - 1062
  • [5] Gut microbiota and probiotics intervention: A new therapeutic target for management of chronic kidney disease
    Zhu, Han
    Yao, Ying
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (03): : 291 - 297
  • [6] Gut Microbiota in Vascular Disease: Therapeutic Target?
    Anbazhagan, A. N.
    Priyamvada, S.
    Priyadarshini, M.
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (04) : 291 - 295
  • [7] The Effects of Pro-, Pre-, and Synbiotics on Muscle Wasting, a Systematic Review-Gut Permeability as Potential Treatment Target
    Van Krimpen, Sandra J.
    Jansen, Fleur A. C.
    Ottenheim, Veerle L.
    Belzer, Clara
    van der Ende, Miranda
    van Norren, Klaske
    NUTRIENTS, 2021, 13 (04)
  • [8] Platinum-induced muscle wasting in cancer chemotherapy: Mechanisms and potential targets for therapeutic intervention
    Moreira-Pais, Alexandra
    Ferreira, Rita
    da Costa, Rui Gil
    LIFE SCIENCES, 2018, 208 : 1 - 9
  • [9] The gut microbiota: A new target in the management of alcohol dependence?
    Leclercq, Sophie
    Starkel, Peter
    Delzenne, Nathalie M.
    de Timary, Philippe
    ALCOHOL, 2019, 74 : 105 - 111
  • [10] Gut microbiota as a promising therapeutic target for age-related sarcopenia
    Zhang, Ting
    Cheng, Jin-ke
    Hu, Yao-min
    AGEING RESEARCH REVIEWS, 2022, 81